ClinicalTrials.Veeva

Menu

Prevention of Acute Radiation Enteritis With Glutamine

C

Castilla-León Health Service

Status and phase

Completed
Phase 4

Conditions

Acute Radiation Enteritis

Treatments

Dietary Supplement: Glutamine
Dietary Supplement: Whole protein

Study type

Interventional

Funder types

Other

Identifiers

NCT00828399
001-2008-BecaSacyl

Details and patient eligibility

About

Ionizing radiation has cytotoxic effects, and is commonly used as treatment for neoplasm. A common adverse effect of radiation is acute diarrhoea. Glutamine is an aminoacid with antioxidant effects that can protect tissues of damage dued to radiation. The investigators designed a randomized, double-blind trial phase III to study if glutamine prevents acute radiation enteritis.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 yr
  • Gynaecological,prostatic, rectal or other abdominal cancer
  • Radiotherapy with/without chemotherapy

Exclusion criteria

  • life expectancy < 1 yr
  • Age < 18 yr
  • gut diseases: inflammatory bowel disease,sprue, irritable bowel disease...
  • moderate to severe chronic renal failure
  • hepatic cirrhosis

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

70 participants in 2 patient groups, including a placebo group

Glutamine
Experimental group
Treatment:
Dietary Supplement: Glutamine
Whole protein
Placebo Comparator group
Treatment:
Dietary Supplement: Whole protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems